Login / Signup

Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.

Marek KrzystanekMarek AsmanJoanna WiteckaArtur PałaszRyszard Wiaderkiewicz
Published in: Pharmacological reports : PR (2020)
The finding indicates that selected single nucleotide variants in GRIN2A and GRIN2B encoding subunits of the NMDA receptor are not associated with the presence of cognitive deficits in schizophrenia.
Keyphrases
  • bipolar disorder
  • cognitive impairment
  • copy number
  • cancer therapy
  • gene expression
  • genome wide